Abstract A recent comparative proteomics study identified the short-chain dehydrogenase (Sch1) as being required for asexual sporulation (Tan et al. Eukaryotic Cell 7:1916-1929. Metabolite profiling was undertaken on the mutant strains of Stagonospora nodorum lacking the Sch1 gene to help elucidate its role. Gas chromatography-mass spectrometry of the polar metabolites in the Sch1 mutants identified a secondary metabolite at a 200-fold greater concentration than observed in the wild-type strains. Comparative analysis of the secondary metabolite and the mycotoxin alternariol using ESI-MS/MS confirmed the identity of the compound as alternariol. This is the first report to confirm the presence of a mycotoxin in S. nodorum and compelling the field to consider the health implication of this disease.
Introduction
Stagonospora (syn. Septoria) nodorum (Berk.) Castell. and Germano [teleomorph: Phaeosphaeria (syn. Leptosphaeria) nodorum (Müll.) Hedjar.] is a major pathogen of wheat and other cereals (Solomon et al. 2006a) . In wheat, the disease is called stagonospora nodorum blotch, septoria nodorum blotch and glume blotch. Previous studies focused on understanding the disease have demonstrated critical roles for host-specific proteinaceous toxins and various primary metabolic pathways for effective fungal pathogenicity (for review, see Solomon et al. 2006a) .
Signal transduction pathways within S. nodorum also have required roles for pathogenicity (Solomon et al. 2004 (Solomon et al. , 2005 (Solomon et al. , 2006c . Each of the cAMP-dependent, the MAP kinase and the Ca 2? signalling pathways all have demonstrated roles in enabling S. nodorum to complete its pathogenic lifecyle. It is unclear though what downstream genes and proteins are regulated by these signalling pathways. Recent studies in S. nodorum have used comparative proteomics to identify Sch1, a gene encoding a hypothetical short-chain dehydrogenase as being positively regulated by Ga subunit (Gna1) and a MAP kinase protein (Mak2) (Tan et al. 2008) . Subsequent characterisation of the strains of S. nodorum lacking Sch1 showed that the gene was required for asexual development. Detailed transcript and histological analysis identified that Sch1 was required for the maturation of the asexual fruiting body pycnidia. However, it was unclear from these approaches how.
In this study, we exploit the power of metabolomics to compare the metabolome of the Sch1 mutants to that of the wild-type to investigate the function of this gene. Metabolomics has many well documented strengths that complement the existing 'omics technologies with metabolic information often viewed as reflecting biological endpoints more accurately than transcript or protein analysis (Harrigan et al. 2007) . Thus the aim of this study was to use metabolomics to shed light on the role of Sch1 in the pathogen S. nodorum.
Experimental methods

Growth and maintenance of fungal strains
S. nodorum wild-type SN15 was obtained from Department of Agriculture, Western Australia. The sch1 mutants used during this study were developed and described previously (Tan et al. 2008 ). The strains sch1-11 and sch1-42 are mutants whereby the Sch1 gene has been deleted. The strain Sch1-30 harbours an ectopic copy whereby the deletion construct that was transformed into S. nodorum integrated into the genome in a heterologous manner. This strain is essentially a control for the transformation process and is expected to behave as per the wild-type isolate. All fungal strains were grown on defined minimal medium (MM) which consisted of 6 g l -1 glucose, 2 g l -1 NaNO 3 -, 1.0 g l -1 K 2 HPO 4 , 0.5 g l -1 KCl, 0.5 g l (Solomon et al. 2004 ). The inoculated MM plates were incubated for two weeks at 22°C in 12 h cycles of darkness and near-UV light (Phillips TL 40 W/ 05) prior to harvesting.
Gas chromatography-mass spectrometry metabolite analysis
Metabolite analysis of S. nodorum was adapted from previous studies (Solomon et al. 2006b (Solomon et al. , 2006d Lowe et al. 2008) . Approximately 10 mg of fungal mycelia were scraped from MM agar plates using a sterile scalpel blade (No. 10) into a pre-weighed 2 ml microfuge tube. One MM agar plate represented one biological replicate and six to eight replicates were used per strain. The tube was immediately immersed in liquid nitrogen prior to freeze drying and being re-weighed. 700 ll of -40°C pure methanol containing 50 lM ribitol was added to the mycelia and vortexed briefly. The tube was then placed in liquid nitrogen and then thawed on ice. The mycelia were then separated from the extracted metabolites by centrifugation at 21,000 g for 2 min and 4°C. The supernatant was removed and placed in a new 2 ml microfuge tube whilst a further 700 ll of -40°C methanol containing 50 lM ribitol was added to the mycelia and the freeze/thaw process repeated. The mycelia suspension was again centrifuged and the supernatant was added to the original supernatant which was then freeze dried prior to derivatisation. Methoximation of carbonyl groups was performed by addition of 50 ll methoxylamine-HCl (20 mg/ml in pyridine) to the dried metabolites followed by incubation at 30°C for 90 min with shaking. Trimethylsilyl (TMS) esters were then created by addition of 80 ll N-trimethylsilyl-Nmethyl trifluoroacetamide (MSTFA) and incubation at 37°C for 30 min.
For the gas chromatography-mass spectrometry (GC-MS) analysis, samples were injected as 1 ll derivatised metabolites in a 20:1 split ratio. The GC-MS equipment consisted of an Agilent 7680 autosampler, an Agilent 6890 gas chromatograph and an Agilent 5973 N quadrupole mass spectrometer (Agilent, Palo Alto, CA, USA). The GC-MS system was auto-tuned using perflurotributylamine (PFTBA). A 30 m Varian VF-5 ms column with a 10 m integrated Varian EZ-Guard column was used for the gas chromatography (Varian, Palo Alto, CA, USA). Injection temperature was 230°C, interface temperature was 300°C and the ion source temperature was 230°C. The carrier gas (helium) flow rate was retention-time locked to elute mannitol-TMS at 30.6 min. The temperature gradient consisted of an initial temperature of 70°C increasing 1°C per min for 5 min before increasing to a final temperature of 300°C at a temperature ramp rate of 5.6°C per min. Mass spectra and chromatograms were normalized to the ribitol internal standard and the weight of the sample and processed using AnalyzerPro (SpectralWorks Ltd, Runcorn, U.K.) employing the MatrixAnalyser function. For each strain, between six and eight biological replicates were used.
Data analyses were undertaken using The Unscrambler (Camo) and the JMP7 package (SAS Institute). Statistical significance was determined using the Tukey-Kramer analysis. Principal Component Analysis of the GC-MS data were performed subsequent to log 10 (x ? 1) transformation of the normalised abundance data.
ESI-MS/MS
Samples were prepared as above with the exception that ribitol was not included. The dried extracts were redissolved in 50:50 acetonitrile:water with 0.1% formic acid and infused at 5 ll/min into a Varian 320-MS triple quadrupole mass spectrometer. The ESI ionising conditions in positive mode were as follows; nebulising gas (N 2 ) pressure was 15 psi, drying gas (N 2 ) was at 10 psi and 300°C, electrospray needle voltage was 5000 V, shield voltage was 600 V and capillary voltage was 65 V. Scan range was 100-300 amu, with a scan time of 0.5 s. Automated MS/MS breakdown analysis was performed (using argon as collision gas) with the optimal collision energy determined to be -11 V. The data were analysed using Varian MS Workstation 6.9.
Results
A non-targeted metabolomics approach was used to characterise the Sch1 mutation in S. nodorum. Representative chromatograms displaying total ion counts (TIC) are shown in Fig. 1 . Approximately 223 metabolites, both of known and unknown identity, were resolved under the separation conditions. Immediately apparent was the accumulation of a late eluting unknown compound at 45.57 min (named RT4557) in the sch1 strains.
The abundances of each metabolite in all strains were subjected to multivariate analysis. The Principal Component Analysis (PCA) score plot for PC1 and PC2 is shown in Fig. 2a . PC1 captured 88% variance and clustered the wild-type and ectopic strains from the mutants. PC2 accounted for 6% of the variance. Factor loadings of PC1 revealed it to be predominantly influenced by RT4557 (Fig. 2b) . Glutamate, glutamine and pyroglutamate also The y-axes are in a log-scale. The elution of RT4557 is marked with an arrow contributed to PC1 although statistical analysis of the compounds influencing PC1 found that only RT4557 differed significantly when comparing the four strains. A comparison of the relative abundance of RT4557 found it to accumulate in the sch1 mutants to approximately 200-fold the levels measured in SN15 and Sch1-30 (Fig. 2c) .
A comparison of the RT4557 fragmentation pattern with existing libraries (NIST05 and Wiley) was unable to determine the identity of the compound. Consequently, a series of complementary analyses were undertaken to resolve its identity. Firstly, the mass of the derivatised parental ion was sought using chemical ionisation (CI).
Positive CI using methane yielded a base peak of 475 m/z compared to 459 m/z base peak for electron ionisation (data not shown). The mass of the derivatised RT4557 was determined as 474 as this species is singularly charged. Allowing for the additional mass due to the presence of trimethyl silyl group(s), the molecular weight of the underivatised RT4557 was likely to be either 402 (1TMS), 330 (2TMS), 258 (3TMS) or 186 (4TMS).
RT4557 was then purified using liquid chromatography with a C 18 column. A large peak eluting at a retention time of 27 mins was present in the sch1 extracts but not SN15 (data not shown). These fractions were collected with an aliquot derivatised and re-analysed using GC-MS to confirm the identity of the peak as RT4557. A large peak was identified at retention time of 45.57 min. The fragmentation pattern of the compound was almost identical to the previously identified RT4557, albeit appearing less fragmented. Subsequent analysis of this cleaner fragmentation pattern using AnalyzerPro and the NIST05 database revealed a significant match to 3,7,9-Tris[(trimethylsilyl)oxy]-1-methyl(6H)dibenzo [b,d] pyran-6-one, the trimethylsilylated derivative of the mycotoxin alternariol (CAS number 641-38-3) (Fig. 3) .
To confirm the identity of RT4557 as alternariol, a small amount of standard was purchased (Sigma). Analysis of the alternariol standard using GC-MS found it eluted at 45.57 min, the precise time of RT4557 elution (data not shown). The pure alternariol standard was also subjected to direct infusion electrospray ionisation-mass spectrometry (ESI-MS) using a Varian 320-MS triple quadrupole mass spectrometer (Fig. 4) . A peak corresponding to 259 m/z was present. Allowing for the compound to be singularly charged, this corresponds to a mass of 258 Da, the empirical mass for alternariol. A more abundant ion corresponding to an acetonitrile adduct was also apparent at 288 m/z. Direct infusion of RT4557 compound after liquid chromatography revealed an identical pattern with peaks at 259 m/z and 288 m/z identified providing further evidence of the identity of RT4557 as alternariol. A mass of 258 Da correlates well with the chemical ionisation data. Fragmentation of the 259 m/z ion identified from the RT4557 sample revealed a near identical fragmentation pattern to the standard further substantiating the identity of RT4557 as alternariol as well as previously published MS/MS data for the compound (Scott et al. 1997) .
Discussion
The aim of this study was to determine the role of Sch1 using a metabolomics approach. A combination of GC-MS (EI and CI) and ESI-MS/MS was used to identify that Sch1 has a role in the synthesis of alternariol. Alternariol is a post-harvest toxin commonly associated with the genus Alternaria and is known to be found in various fruits, cereals and processed fruit products (Scott 2001) . The consumption of foods contaminated with alternaria toxins including alternariol has been previously associated with esophageal cancer with other reports commenting on its mutagenicity and toxicity (Brugger et al. 2006; Lehmann et al. 2006; Pfeiffer et al. 2007 ). The toxins altenuene and tenuazonic acid, often associated with alternaria infections, were not detected during the course of this study (data not shown). This study has provided two significant novel findings. Firstly, mycotoxins have until now yet to be identified in S. nodorum. S. nodorum is associated with significant yield losses throughout the world. Identifying this pathogen as a mycotoxin producer is novel and will require experts involved in managing the disease to now consider this. No longer can S. nodorum be singularly associated with inflicting yield losses and it should now be considered a health risk and treated as such.
The second novel finding from this study is the involvement of a short-chain dehydrogenase in the synthesis of alternariol. Surprisingly, the synthesis of alternariol in vivo is poorly understood with any of the genes involved yet to be identified. Sch1 is a short chain dehydrogenase of unknown function but has a demonstrated role in maturation of asexual sporulation structures known as pycnidia (Tan et al. 2008) . At this point, it is difficult to comment on putative roles of Sch1 apart from speculating on it being a potential negative regulator of alternariol production. Sch1 may also be involved in the processing of alternariol to an unidentified downstream product. However, further studies are required to confirm this.
This study also raises many interesting questions regarding the capacity of fungi to produce secondary metabolites. Without the disruption of Sch1, it is unlikely that the ability of S. nodorum to synthesize toxin would have been realised.
Conclusion
In this study, a series of complementary platforms have been used to demonstrate for the first time that S. nodorum has the capacity to synthesize a mycotoxin. Such a finding highlights the power of a non-biased metabolomics approach and has shed new light on this disease. Alternariol is a post-harvest mycotoxin in Alternaria spp. and studies are now underway correlating the presence of alternariol with S. nodorum infections in post-harvest fields and also stored grain. 
